WHO, African Medicines Agency Sign Major Regulatory Pact for Africa
WHO and the African Medicines Agency inked a landmark collaboration to boost regulatory harmonization in Africa.
Why it matters: The agreement sets a new direction for regulatory compliance in Africa, impacting pharmaceutical companies and legal practitioners engaged in global health markets. Companies will face a more unified set of requirements for quality and safety.
- The Framework Agreement was signed on May 21, 2026, during the 79th World Health Assembly in Geneva.
- The Partnership aims to harmonize, converge, and strengthen regulatory systems continent-wide over the next 3–5 years.
- AMA, headquartered in Kigali, Rwanda, was created under a 2019 treaty that entered into force in 2021.
- Joint operational plans will guide regulatory reforms and prioritize collaboration between WHO, AMA, and African nations.
The World Health Organization and the African Medicines Agency (AMA) formally signed a Framework Agreement on May 21, 2026, marking a significant leap towards unifying health product regulation across Africa. The event occurred during the Seventy-ninth World Health Assembly in Geneva, gathering top health and regulatory leaders from across the continent.
- The collaboration aims to advance regulatory harmonization, convergence, and reliance, supporting both national agencies and the broader mission of AMA, which was established by an African Union treaty adopted in 2019 and enforced in 2021.
- Joint operational plans over the next three to five years outline priorities and deliverables for building stronger, more trusted regulatory processes—potentially simplifying compliance for international and local pharma sectors.
- Dr. Yukiko Nakatani, WHO Assistant Director-General for Health Systems, noted, “Strong regulatory systems are a pillar of resilient health systems and fundamental to health sovereignty, health security and equitable access to safe and quality-assured health products.”
- AMA Director-General Dr. Delese Mimi Darko emphasized, “Strong regulation is ultimately about protecting lives and building public trust. Every person in Africa should have confidence that the medicines, vaccines and other health products they receive meet the highest standards of quality, safety and efficaciousness.”
The Framework Agreement builds on the African Union–WHO Memorandum of Understanding renewed in May 2025, reinforcing strategic alignment on regulatory reforms and access to safe health products. As Dr. Mohamed Yakub Janabi, WHO Regional Director for Africa, highlighted, the success of AMA will be judged by its real-world impact—safer medicines, swifter access, and better health security continent-wide.
By the numbers:
- May 21, 2026 — Framework Agreement signing date
- 3–5 years — Timeline for joint operational plans
- 2019 — Year AMA Treaty adopted; entered into force in 2021
Yes, but: Specific details of the joint operational plans and their implementation timelines remain undisclosed.